Candel Therapeutics (CADL) Return on Sales [ROS] (2020 - 2023)
Candel Therapeutics (CADL) recorded Return on Sales [ROS] of -9444.12% in Q1 2023, up 19542.98 percentage points from -28987.10% a year earlier and up 16688.14 percentage points from the prior quarter.
Candel Therapeutics (CADL) Return on Sales [ROS] (2020 - 2023) Analysis & Trends
On a TTM basis, Candel Therapeutics' Return on Sales [ROS] came in at -18137.44% as of Mar 31, 2023, up 6101.27 percentage points year-over-year; for FY2022, it was -27777.60%, down 7196.80 percentage points from FY2021.
- Across earlier years, Return on Sales [ROS] came in at -20580.80% in FY2021 (-9532.80 pp) and -11048.00% in FY2020.
- The Q1 2023 figure is the highest quarterly Return on Sales [ROS] since Q3 2020.
- On a year-over-year basis, Return on Sales [ROS] rose in 1 of the last eight quarters, with an average year-over-year change of -5045.43 percentage points.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 19542.98 percentage points in Q1 2023, against a drop of 17032.26 percentage points in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -26132.26% (Q4 2022), -28648.39% (Q3 2022) and -28235.48% (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Candel Therapeutics | 711.71 Mn | 108.61 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -9,444.12% |
| Dec 31, 2022 | -26,132.26% |
| Sep 30, 2022 | -28,648.39% |
| Jun 30, 2022 | -28,235.48% |
| Mar 31, 2022 | -28,987.10% |
| Dec 31, 2021 | -24,967.74% |
| Sep 30, 2021 | -25,900.00% |
| Jun 30, 2021 | -17,100.00% |
| Mar 31, 2021 | -15,022.58% |
| Dec 31, 2020 | -19,758.06% |
| Sep 30, 2020 | -8,867.74% |
| Jun 30, 2020 | -8,448.39% |
Candel Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CADL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CADL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CADL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();